Douglas M. Schirle
Analyst · Far View Capital management
The quarter ended March 31, 2013, was our 38th consecutive profitable quarter. We reported net income of $950,000 or $0.03 per diluted share and net revenues of $15.7 million for our fourth fiscal quarter ended March 31, 2013, compared to net income of $800,000 or $0.03 per diluted share and net revenues of $18.7 million in the comparable period a year ago. In the prior quarter ended December 31, 2012, we earned $844,000 or $0.03 per diluted share, and net revenues of $17.5 million. For the year, we reported net income of $3.8 million or $0.14 per diluted share and net revenues of $66 million compared to net income of $6.7 million or $0.22 per diluted share and net revenues of $82.5 million in the fiscal year ended March 31, 2012. Gross margin was 43.3% compared to 44.4% in the prior year. Fourth quarter direct and indirect sales to Cisco Systems were $3.9 million or 24.8% of net revenues compared to $6.5 million or 37% of net revenues in the prior quarter, and $6 million or 32.1% of net revenues in the same period a year ago. We believe the decline in sales to Cisco was due to interim corrections and softness in demand for the products and do not reflect a decline in our market share. Military/defense sales were 12.7% of shipments compared to 11% of shipments in the prior quarter, and 11.1% of shipments in the comparable period a year ago. SigmaQuad sales were 38.9% of shipments compared to 33.7% in the prior quarter and 38.3% in the fourth quarter of fiscal 2012. Fourth quarter fiscal 2013 operating income was $439,000 or 2.8% of net revenues compared to $595,000 or 3.4% of net revenues in the prior quarter, and an operating loss of $83,000 a year ago. Total operating expenses were $6.8 million compared to $6.7 million in the prior quarter and $8.7 million a year ago. Research and development expenses of $2.9 million were unchanged from prior quarter and slightly higher than the $2.7 million reported a year ago. Selling, general and administrative expenses were $3.9 million compared to $3.9 million -- $6.1 million in the fourth quarter of fiscal 2012. Included in SG&A during these periods were respectively: $1.2 million, $1.1 million, and $3.7 million in litigation-related expenses. Total fourth quarter pretax stock-based compensation expense was $589,000 compared to $565,000 in the prior quarter and $539,000 in the comparable quarter a year ago. For the full year period, total pretax stock-based compensation was $2.3 million in fiscal 2013, compared to $2.1 million in fiscal 2012. At March 31, 2013, we had $67.3 million in cash, cash equivalents and short-term investments, $35.5 million in long-term investments, $86.6 million working capital, no debt and stockholders' equity of $132.2 million. Accounts payable at March 31, 2013, was $3.8 million compared to $5.5 million at March 31, 2012. Net inventory was $13.8 million at March 31, 2013, down from $16.7 million at March 31, 2012. Inventory turns at March 31, 2013, were 2.4x compared to 2.4x at March 31, 2012. Depreciation and amortization expense was $2.4 million in fiscal 2013. We currently expect net revenues in the first quarter of fiscal 2014 to be in the range of $15 million to $16 million with gross margin of approximately 43%. We also expect ongoing legal expenses related to the patent litigation and antitrust litigation will continue to affect our operating income and our bottom line. These expenses are difficult to forecast but we currently estimate that they will be approximately $2 million in the first quarter. Operating expenses in total are expected to be 5 -- approximately $7.5 million. Operator, at this point, we'll open the call to Q&A.